CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $410,363 | +74920.7% | 318,111 | 0.0% | 0.09% | -23.5% |
| Q2 2023 | $547 | +14.0% | 318,111 | 0.0% | 0.12% | +17.8% |
| Q1 2023 | $480 | -5.7% | 318,111 | -0.0% | 0.10% | -12.2% |
| Q4 2022 | $509 | -99.9% | 318,233 | +2.2% | 0.12% | +9.5% |
| Q3 2022 | $451,000 | +18.7% | 311,315 | +49.8% | 0.10% | +22.1% |
| Q2 2022 | $380,000 | – | 207,772 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |